Cystacin C-based eGFR and Creatinine Clearance-based eGFR in Patients with Severe Motor and Intellectual Disabilities
JMA J
.
2023 Oct 16;6(4):487-488.
doi: 10.31662/jmaj.2023-0137.
Epub 2023 Oct 4.
Authors
Kouichi Tamura
1
,
Toshikazu Takizawa
2
,
Gaku Shimura
3
,
Toshiharu Kokuho
4
Affiliations
1
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
2
Department of Renal Medicine, Hadano Red Cross Hospital, Hadano, Japan.
3
Department of Nephrology, Yokosuka General Uwamachi Hospital, Yokosuka, Japan.
4
Department of Renal Medicine, Yokosuka City Hospital, Yokosuka, Japan.
PMID:
37941694
PMCID:
PMC10628330
DOI:
10.31662/jmaj.2023-0137
No abstract available
Keywords:
Chronic kidney disease; Cystatin C; Kidney function.
Publication types
Editorial